Flutamide counteracts the antiproliferative effects of antiprogestins in the primate endometrium

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 2, 2003, Pages 946-949

  Slayden, Ov D ^a   Brenner, Robert M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA (4 ACETYLPHENYL) 17BETA HYDROXY 17ALPHA (1,1,2,2,2 PENTAFLUOROETHYL)ESTRA 4,9 DIEN 3 ONE; ANDROSTANOLONE; ANTIANDROGEN; ANTIGESTAGEN; ESTRADIOL; FLUTAMIDE; HYDROCORTISONE; TESTOSTERONE; UNCLASSIFIED DRUG; ZK 137316;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIUM; EPITHELIUM CELL; FEMALE; HISTOLOGY; HORMONE BLOOD LEVEL; MITOSIS; MORPHOMETRICS; NONHUMAN; PRIMATE; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; CELL DIVISION; ENDOMETRIUM; ESTROGENS; FEMALE; FLUTAMIDE; MACACA MULATTA; MITOSIS; ORGAN SIZE; PROGESTERONE; STEROIDS; STROMAL CELLS;

ANIMALIA; MACACA; MACACA MULATTA; PRIMATES;

EID: 0037326357     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021763     Document Type: Article

References (22)

1. Slayden OD, Brenner RM 1994 RU 486 action after estrogen priming in the endometrium and oviducts of rhesus monkeys (Macaca mulatta). J Clin Endocrinol Metab 78:440-448.
2. Slayden OD, Zelinski-Wooten MB, Chwalisz K, Stouffer RL, Brenner RM 1998 Chronic treatment of cycling rhesus monkeys with low doses of the antiprogestin ZK 137 316: morphometric assessment of the uterus and oviduct. Hum Reprod 13:269-277.
3. Slayden OD, Chwalisz K, Brenner RM 2001 Reversible suppression of menstruation with progesterone antagonists in rhesus macaques. Hum Reprod 16:1562-1574.
4. Wolf JP, Hsiu JG, Anderson TL, Ulmann A, Baulieu EE, Hodgen GD 1989 Noncompetitive antiestrogenic effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril 52:1055-1060.
5. Cameron ST, Critchley HOD, Thong KJ, Buckley CH, Williams AR, Baird DT 1996 Effects of daily low dose mifepristone on endometrial maturation and proliferation. Hum Reprod 11:2518-2526.
6. Chwalisz K, Brenner RM, Fuhrmann U, Hess-Stumpp H, Elger W 2000 Antiproliferative effects of progesterone antagonists and progesterone receptor modulators (PRMs) on the endometrium. Steroids. 65:741-751.
7. Brenner RM, Slayden OD 1994 Cyclic changes in the primate oviduct and endometrium. In: Knobil E, Neill JD, eds. The Physiology of Reproduction. New York: Raven Press; 541-569.
8. Kettel LM, Murphy AA, Morales AJ 1996 Treatment of endometriosis with the antiprogesterone mifepristone (RU486). Fertil Steril 65:23-28.
9. Bygdeman M, Danielsson KG, Marions L, Swahn M-L 1999 Contraceptive use of antiprogestin. The European Journal of Contraception and Reproductive Health Care. 4:103-107.
10. Slayden OD, Nayak NR, Burton KA, Chwalisz K, Cameron ST, Critchley HOD, Baird DT, Brenner RM 2001 Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 86:2668-2679.
11. Grody MH, Lampe EH, Masters WH 1953 Estrogen-androgen substitution therapy in the aged female. Obstet Gynecol 2:36-45.
12. Slayden OD, Hirst JJ, Brenner RM 1993 Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment. Endocrinology. 132:1845-1856.
13. Singh SM, Gauthier S, Labrie F 2000 Androgen receptor antagonists (antiandrogens): Structure-activity relationships. Current Medicinal Chemistry 7:211-247.
14. Montalvo L, Sanchez-Chapado M, Prieto J, Carmena M 2002 Regulation of the expression of protein kinase C isoenzymes in rat ventral prostate: effects of age, castration and flutamide treatment. Life Sci 71:2257-2266.
15. Chen C, Poulin R, Labrie F 1996 Large Shionogi tumors lose their responsiveness to flutamide treatment. J Steroid Biochem Mol Biol 58:489-494.
16. Neri R 1989 Pharmacology and pharmacokinetics of flutamide. Urology Suppl 34:19-21.
17. th ed. New York: Marcel Dekker, Inc.
18. Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH, Chwalisz K 2000 Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 43:5010-5016.
19. Apparao KB, Lovely LP, Gui Y, Lininger RA, Lessey BA 2002 Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66:297-304.
20. Ajossa S, Guerriero S, Paoletti AM, Orru M, Melis GB 2002 The antiandrogenic effect of flutamide improves uterine perfusion in women with polycystic ovary syndrome. Fertil Steril 77:1136-1140.
21. Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP 2002 Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia. J Clin Endocrinol Metab 87:3197-3200.
22. Chandrasekhar Y, Armstrong DT 1991 Regulation of uterine progesterone receptors by the nonsteroidal antiandrogen hydroxyflutamide. Biol Reprod 45:78-81.